Dr. Marc Carrier, MD
Claim this profileThe Ottawa Hospital
Affiliated Hospitals
The Ottawa Hospital
Clinical Trials Marc Carrier, MD is currently running
Anticoagulation Strategies
for Blood Clots in Cancer Patients
Patients with cancer are prone to have blood clots, which are usually treated with blood thinners. The main complication of blood thinners is bleeding. This is especially a concern when the number of platelets in the blood is lower than 50,000 per microliter. The role of platelets is to stop bleeding, so when the number of platelets is low, patients are at a higher risk of bleeding. Cancer patients are prone to have lower platelet numbers due to cancer therapies and/or cancer itself. It is not clear what the best treatment is for cancer patients who need blood thinners for a blood clot but have low platelet counts. The investigators plan to do a small study called a pilot study to help plan for a larger study in such patients. In the pilot study, investigators will include 50 patients with cancer, low platelet counts, and a blood clot diagnosed within 2 weeks. Patients will be randomly assigned to one of the two treatment strategies: the full dose of blood thinners along with platelet transfusion or a reduced dose of blood thinners without platelet transfusion. The investigators will follow all patients for 30 days. If this pilot study is successful, it will help lead to a much larger trial, which will provide important information on the best treatment strategy for these patients.
Recruiting
5 awards
Phase 4
4 criteria
Surveillance vs. Rivaroxaban
for Pulmonary Embolism
The clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE), remains controversial. Whether isolated SSPE represents "true" PE, a clinically more benign form of PE, a physiologic lung clearing process, or a false positive result (artifact) is currently unclear and hence, whether patients with isolated SSPE benefit from anticoagulant treatment is uncertain. Despite growing evidence from observational studies that withholding anticoagulation may be a safe option in selected patients with isolated SSPE (i.e., those without concomitant deep vein thrombosis, cancer, etc.), most patients with isolated SSPE receive anticoagulant treatment, which is associated with an increased risk of bleeding. The overall objective of the randomized controlled SAFE-SSPE trial is to evaluate the efficacy and safety of clinical surveillance without anticoagulation compared to anticoagulation treatment in low-risk patients with isolated SSPE.
Recruiting
2 awards
Phase 4
3 criteria
More about Marc Carrier, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Marc Carrier, MD has experience with
- Rivaroxaban
- Dalteparin
- Enoxaparin
- Tinzaparin
- Placebo
- Limited Cancer Screening
Breakdown of trials Marc Carrier, MD has run
Deep Vein Thrombosis
Venous Thromboembolism
Pulmonary Embolism
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc Carrier, MD specialize in?
Marc Carrier, MD focuses on Deep Vein Thrombosis and Venous Thromboembolism. In particular, much of their work with Deep Vein Thrombosis has involved treating patients, or patients who are undergoing treatment.
Is Marc Carrier, MD currently recruiting for clinical trials?
Yes, Marc Carrier, MD is currently recruiting for 6 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Marc Carrier, MD has studied deeply?
Yes, Marc Carrier, MD has studied treatments such as Rivaroxaban, Dalteparin, Enoxaparin.
What is the best way to schedule an appointment with Marc Carrier, MD?
Apply for one of the trials that Marc Carrier, MD is conducting.
What is the office address of Marc Carrier, MD?
The office of Marc Carrier, MD is located at: The Ottawa Hospital, Ottawa, Ontario K1H 8L6 Canada. This is the address for their practice at the The Ottawa Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.